LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs

Photo from archive.org

Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging to the genus Leishmania . In humans, it has two main clinical forms, visceral leishmaniasis (VL) and… Click to show full abstract

Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging to the genus Leishmania . In humans, it has two main clinical forms, visceral leishmaniasis (VL) and cutaneous or tegumentary leishmaniasis (CL), as well as several other cutaneous manifestations in a minority of cases. In the mammalian host Leishmania parasites infect different populations of macrophages where they multiply and survive in the phagolysosomal compartment. The progression of both VL and CL depends on the maintenance of a parasite-specific immunosuppressive state based around this host macrophage infection. The complexity and variation of immune responses and immunopathology in humans and the different host interactions of the different Leishmania species has an impact upon the effectiveness of vaccines, diagnostics and drugs.

Keywords: immunopathology impact; leishmaniasis; leishmaniasis immunopathology; vaccines diagnostics; immunopathology; diagnostics drugs

Journal Title: Seminars in Immunopathology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.